Literature DB >> 6703679

Effect of temocillin in combination with other beta-lactam antibiotics.

L Verbist, J Verhaegen.   

Abstract

The antibacterial interactions of temocillin with other beta-lactams were tested by checkerboard combination in Mueller-Hinton agar against 146 strains of members of the family Enterobacteriaceae, 35 Pseudomonas aeruginosa strains, and 35 Staphylococcus aureus strains. Most combinations showed a moderate degree of synergism. In only one Klebsiella strain was minor antagonism observed between temocillin and ampicillin.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6703679      PMCID： PMC185455          DOI： 10.1128/AAC.25.1.142

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.

Authors:  K P Fu; H C Neu
Journal:  J Antimicrob Chemother       Date:  1981-03       Impact factor: 5.790

2.  Synergism and antagonism of ceftizoxime and other new cephalosporins.

Authors:  R C Moellering; S Willey; G M Eliopoulos
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

3.  Combination of ceftizoxime with azlocillin, mezlocillin, piperacillin and ticarcillin.

Authors:  H C Neu
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

4.  Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.

Authors:  H C Neu; P Labthavikul
Journal:  J Antimicrob Chemother       Date:  1982-01       Impact factor: 5.790

5.  BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.

Authors:  B Slocombe; M J Basker; P H Bentley; J P Clayton; M Cole; K R Comber; R A Dixon; R A Edmondson; D Jackson; D J Merrikin; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

6.  In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

7.  Antibacterial activity and beta-lactamase stability of temocillin.

Authors:  K Jules; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191
  7 in total
  7 in total

1.  In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori.

Authors:  T Alarcón; D Domingo; I Sánchez; F Díaz de Rojas; M López-Brea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

2.  Influence of temocillin on human bowel flora.

Authors:  H W Mittermayer
Journal:  Drugs       Date:  1985       Impact factor: 9.546

3.  Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus.

Authors:  Y Utsui; S Ohya; T Magaribuchi; M Tajima; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

4.  Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strains.

Authors:  I Haller
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

5.  Prevention of bacteremia caused by alpha-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin.

Authors:  M Rozenberg-Arska; A Dekker; L Verdonck; J Verhoef
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

6.  Amoxicillin plus temocillin as an alternative empiric therapy for the treatment of severe hospital-acquired pneumonia: results from a retrospective audit.

Authors:  H Habayeb; B Sajin; K Patel; C Grundy; A Al-Dujaili; S Van de Velde
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-19       Impact factor: 3.267

Review 7.  Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic.

Authors:  Tommaso Lupia; Ilaria De Benedetto; Giacomo Stroffolini; Stefano Di Bella; Simone Mornese Pinna; Verena Zerbato; Barbara Rizzello; Roberta Bosio; Nour Shbaklo; Silvia Corcione; Francesco Giuseppe De Rosa
Journal:  Antibiotics (Basel)       Date:  2022-04-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.